Detalhe da pesquisa
1.
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.
Lancet HIV
; 9(5): e332-e340, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35489377
2.
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings.
Open Forum Infect Dis
; 9(7): ofac325, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35899273
3.
Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
AIDS
; 31(16): 2217-2225, 2017 10 23.
Artigo
Inglês
| MEDLINE | ID: mdl-28742529